New Delhi: Eleven individuals who received the AstraZeneca-Oxford COVID-19 vaccine have developed a rare neurological disorder called Guillain-Barre syndrome, clinicians in India and England have reported in two separate studies. The studies, published in the peer-reviewed medical journal ‘Annals of Neurology’, describe an unusual variant of Guillain-Barre syndrome characterised by prominent facial weakness. All the 11 cases were among people who had received that vaccine 10-22 days earlier. Seven cases were reported from a regional medical centre in Kerala, India, where approximately 1.2 million people were vaccinated with the AstraZeneca COVID-19 vaccine till April 22. The cases occurred
Hence then, the article about covid 19 astrazeneca vaccine linked to rare neurological disorder in india england was published today ( ) and is available onGulf News ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( COVID-19: AstraZeneca vaccine linked to rare neurological disorder in India, England )